According to the latest report by IMARC Group, titled ” Antifungal Drugs Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026,” the global antifungal drugs market exhibited moderate growth during 2015-2020. Looking forward, IMARC Group expects the market to grow at a CAGR of around 4% during 2021-2026.
We are regularly tracking the direct effect of COVID-19 on the market, along with the indirect influence of associated industries. These observations will be integrated into the report.
Request Free Report Sample: https://www.imarcgroup.com/antifungal-drugs-market/requestsample
Antifungal drugs, or antimycotic drugs, are pharmaceutical medicines utilized for treating fungal infections on the nails, skin, hair, etc. Polyenes, azoles, allylamines, etc., are some of the commonly used antifungal drugs across the globe. These medications neutralize fungal agents and dermatophytes, such as tapeworms and candida, and aid in treating aspergillosis, ringworm, candidiasis, fungal meningitis, etc. Antifungal drugs are generally obtainable in the over-the-counter (OTC) gel, liquid, capsule, and pill variants or as intravenous solutions injected directly into the bloodstream. They are available in clinics, hospitals, and pharmacies across the globe.
The rising prevalence of nosocomial and fungal infections is one of the key factors driving the antifungal drugs market. Additionally, the shifting preferences among consumers towards OTC therapeutics for the timely treatment of minor infections are further catalyzing the market growth. In line with this, the increasing ease of availability of OTC drugs across urban and rural areas is acting as another significant growth-inducing factor. Furthermore, the development of novel therapeutics in the form of creams, sprays, injections, tablets, etc., with enhanced efficacy is also augmenting the global market. Apart from this, the adoption of semi-synthetic and synthetic azole-based compounds in the treatment of invasive fungal infections is anticipated to fuel the antifungal drugs market over the forecasted period.
Antifungal Drugs Market 2021-2026 Competitive Analysis and Segmentation:
Competitive Landscape With Key Players:
The competitive landscape of the global antifungal drugs market has been studied in the report with the detailed profiles of the key players operating in the market.
Competitive Landscape with Key Players:
- Abbott Laboratories
- Arcadia Consumer Healthcare Inc.
- Astellas Pharma Inc.
- Bayer AG
- GlaxoSmithKline Plc
- Merck & Co. Inc.
- Merck KGaA
- Novartis AG
- Pfizer Inc.
- Sanofi S.A.
- Scynexis Inc.
Key Market Segmentation:
The report has segmented the global antifungal drugs market on the basis of drug class, indication and region.
Breakup by Drug Class:
- Azoles
- Echinocandins
- Polyenes
- Allylamines
- Others
Breakup by Indication:
- Dermatophytosis
- Aspergillosis
- Candidiasis
- Others
Breakup by Region:
- North America
- Asia-Pacific
- Europe
- Latin America
- Middle East and Africa
Explore Full Report with TOC & List of Figure: https://www.imarcgroup.com/antifungal-drugs-market
Key highlights of the report:
- Market Performance (2015-2020)
- Market Outlook (2021-2026)
- Industry Trends
- Market Drivers and Success Factors
- The Impact of COVID-19 on the Global Market
- Value Chain Analysis
- Structure of the Global Market
- Comprehensive mapping of the competitive landscape
If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.
About Us
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Contact US:
IMARC Group
30 N Gould St Ste R
Sheridan, WY 82801 USA – Wyoming
Email: Sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
Americas: – +1 631 791 1145 | Africa and Europe: – +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800
